Trials / Recruiting
RecruitingNCT04533464
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 156 (estimated)
- Sponsor
- Healios K.K. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Single center, prospective, randomized, double-blind, pragmatic Phase 2 clinical study in severely injured trauma patients within hours of hospitalization who have survived initial resuscitation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MultiStem | Intravenous Infusion |
| BIOLOGICAL | Placebo | Intravenous Infusion |
Timeline
- Start date
- 2020-11-09
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2020-08-31
- Last updated
- 2024-05-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04533464. Inclusion in this directory is not an endorsement.